CompletedNot Applicable

Modulation of Biomarkers in Patients With Flesh-eating Bacterial Infections After With Hyperbaric Oxygen Treatment

Denmark65 participantsStarted 2013-02

Plain-language summary

The purpose of this study is to investigate the effects of hyperic oxygen treatment on the immune response in patients with necrotizing soft tissue infections

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * Necrotizing soft tissue infection based on surgical findings * Admitted to/planned to be admitted to the ICU at Rigshospitalet and/or operated for NSTI at Rigshospitalet * Receving a minimum of 1 HBOT Exclusion criteria: * Patients who at the operating theatre were categorized as a non-NSTI patient

What they're measuring

IL-6 as a marker of treatment effects after HBOT

Timeframe: Change from baseline in IL-6 concentration after first HBOT administered during the first 24 hours of admission

Trial details

NCT IDNCT02501382

SponsorOle Hyldegaard

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2015-12-01

View on ClinicalTrials.gov More Necrotizing Soft Tissue Infection trials